Clinical Trial Update: Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating reversal of opioid-induced respiratory depression with opioid antagonists; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use
• Opioid-induced Respiratory Depression

Snippet

Sponsor: Leiden University Medical Center | Conditions: Opioid Induced Respiratory Depression, Chronic Opioid Use | Phase 1 | Status: RECRUITING